SANOFI PASTEUR INC. drug pipeline, global patents

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Patent Expiration
Sanofi Pasteur Inc.	FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT	influenza virus vaccine	Injection	103914	1999-12-09		⤷ Sign Up
Sanofi Pasteur Inc.	YF-VAX	yellow fever vaccine	For Injection	103915	1999-12-09		⤷ Sign Up
Sanofi Pasteur Inc.	MENOMUNE-C	meningococcal polysaccharide vaccine, group c	For Injection	103923	1999-12-09		⤷ Sign Up
Sanofi Pasteur Inc.	MENOMUNE-A	meningococcal polysaccharide vaccine, group a	For Injection	103924	1999-12-09		⤷ Sign Up
Sanofi Pasteur Inc.	MENOMUNE-A/C	meningococcal polysaccharide vaccine, groups a and c combined	For Injection	103925	1999-12-09		⤷ Sign Up
Sanofi Pasteur Inc.	MENOMUNE	meningococcal polysaccharide vaccine, groups a, c, y, and w-135 combined	For Injection	103926	1999-12-09		⤷ Sign Up
Sanofi Pasteur Inc.	MENACTRA	meningococcal (groups a, c, y and w-135) polysaccharide diphtheria toxoid conjugate vaccine	For Injection	125089	2005-01-14		⤷ Sign Up
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Patent Expiration

Sanofi Pasteur Inc. Company Profile